These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9412521

  • 1. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.
    Richardson JD, Aanonsen L, Hargreaves KM.
    J Neurosci; 1998 Jan 01; 18(1):451-7. PubMed ID: 9412521
    [Abstract] [Full Text] [Related]

  • 2. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
    Richardson JD, Aanonsen L, Hargreaves KM.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):R3-4. PubMed ID: 9042616
    [Abstract] [Full Text] [Related]

  • 3. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T, Watanabe C, Okuda K, Sugiyama A, Moriyama T, Sakurada C, Tan-No K, Sakurada S.
    Brain Res Mol Brain Res; 2002 Jan 31; 98(1-2):111-8. PubMed ID: 11834301
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
    Hohmann AG, Tsou K, Walker JM.
    J Neurophysiol; 1999 Feb 31; 81(2):575-83. PubMed ID: 10036261
    [Abstract] [Full Text] [Related]

  • 5. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
    Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, Simone DA.
    Pain; 2001 Sep 31; 93(3):303-315. PubMed ID: 11514089
    [Abstract] [Full Text] [Related]

  • 6. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH, Martin BR.
    Pharmacol Biochem Behav; 1997 Sep 31; 57(1-2):7-12. PubMed ID: 9164547
    [Abstract] [Full Text] [Related]

  • 7. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG, Makriyannis A, Hohmann AG.
    Neuroscience; 2003 Sep 31; 119(3):747-57. PubMed ID: 12809695
    [Abstract] [Full Text] [Related]

  • 8. Two distinctive antinociceptive systems in rats with pathological pain.
    Mao J, Price DD, Lu J, Keniston L, Mayer DJ.
    Neurosci Lett; 2000 Feb 11; 280(1):13-6. PubMed ID: 10696800
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.
    Mason DJ, Lowe J, Welch SP.
    Eur J Pharmacol; 1999 Aug 13; 378(3):237-48. PubMed ID: 10493099
    [Abstract] [Full Text] [Related]

  • 10. The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801.
    Forman LJ.
    Brain Res Bull; 2003 Jul 15; 61(2):153-8. PubMed ID: 12832001
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.
    Chaplan SR, Malmberg AB, Yaksh TL.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):829-38. PubMed ID: 9023297
    [Abstract] [Full Text] [Related]

  • 12. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.
    Mao J, Price DD, Mayer DJ, Lu J, Hayes RL.
    Brain Res; 1992 Apr 03; 576(2):254-62. PubMed ID: 1325239
    [Abstract] [Full Text] [Related]

  • 13. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP, Huffman JW, Lowe J.
    J Pharmacol Exp Ther; 1998 Sep 03; 286(3):1301-8. PubMed ID: 9732392
    [Abstract] [Full Text] [Related]

  • 14. Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesia in mice.
    Sakurada C, Sakurada S, Katsuyama S, Sasaki J, Tan-No K, Sakurada T.
    Brain Res; 1999 Sep 11; 841(1-2):85-92. PubMed ID: 10546991
    [Abstract] [Full Text] [Related]

  • 15. 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice.
    Dogrul A, Gardell LR, Ma S, Ossipov MH, Porreca F, Lai J.
    Pain; 2002 Nov 11; 100(1-2):203-9. PubMed ID: 12435473
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential roles of spinal neurokinin 1/2 receptors in development of persistent spontaneous nociception and hyperalgesia induced by subcutaneous bee venom injection in the conscious rat.
    Zheng JH, Chen J.
    Neuropeptides; 2001 Feb 11; 35(1):32-44. PubMed ID: 11346308
    [Abstract] [Full Text] [Related]

  • 18. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
    Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, James I.
    Pain; 2001 May 11; 92(1-2):91-100. PubMed ID: 11323130
    [Abstract] [Full Text] [Related]

  • 19. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats.
    Begon S, Pickering G, Eschalier A, Mazur A, Rayssiguier Y, Dubray C.
    Br J Pharmacol; 2001 Nov 11; 134(6):1227-36. PubMed ID: 11704642
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.
    Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM.
    Brain Res; 1998 Dec 07; 813(2):323-8. PubMed ID: 9838180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.